¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hypersensitivity pneumonia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® hypersensitivity ÇÑ±Û °ú¹Î, ¿¹¹Î
¼³¸í   
  1. ¾î¶² ¾à¹°À̳ª Àڱؿ¡ ´ëÇÏ¿© °úÀ×¹ÝÀÀÀ» ³ªÅ¸³»´Â ¹æÇâÀ¸·Î ¹ÝÀÀ¼ºÀÌ º¯È­ÇÑ »óÅÂ. °ú¹Î¼º ¹ÝÀÀÀº ¸é¿ª¹ÝÀÀ¿¡ ÀÇÇÏ¿© »ý±â´Â º´Àû °úÁ¤À¸·Î, Áï½ÃÇü¹ÝÀÀ°ú Áö¿¬Çü¹ÝÀÀÀ¸·Î ºÐ·ùµÈ´Ù. ¶ÇÇÑ ´ÙÀ½ÀÇ 4ÇüÀ¸·Î ºÐ·ùµÇ±âµµ ÇÑ´Ù. IÇüÀº Áï½ÃÇü °ú¹Î¼º ¹ÝÀÀ(¿¹ÄÁ´ë anaphylaxis). IIÇüÀº Á¶Á÷Ç׿ø¿¡ ´ëÇÑ Ç×ü¿¡ ÀÇÇÏ¿© »ý±â´Â ¼Õ»ó(¿¹ÄÁ´ë ÄáÆÏµ¶¼º ÄáÆÏ¿°). IIIÇüÀº Ç׿øÇ×üº¹ÇÕ¹°, Æ¯È÷ ¾à°£ÀÇ Ç׿øÀÇ °úÀ׿¡ ÀÇÇÏ¿© Çü¼ºµÇ´Â ¿ëÇØ¼º º¹ÇÕ¹°¿¡ ÀÇÇÏ¿© »ý±â´Â °Í(¿¹ÄÁ´ë ¾Æ¸£Åõ½º ¹ÝÀÀÀ̳ª Ç÷ûº´). IVÇüÀº Áö¿¬Çü °ú¹Ì¼º ¹ÝÀÀ(¿¹ÄÁ´ë Á¢Ã˼º ÇǺκ´)ÀÌ´Ù. 2. °¨°¢À̳ª °¨Á¤ÀÌ Áö³ªÄ¡°Ô ¿¹¹ÎÇÔ.
¿µ¹® pneumonia ÇÑ±Û Æó·Å
¼³¸í   
  ÆóÀÇ ¿°ÁõÀ¸·Î ÆóÆ÷ ³»¿¡ °ø±â ´ë½Å ¿°Áõ ¼¼Æ÷³ª »ïÃâ¾×À¸·Î °¡µæ Â÷ È£Èí°ï¶õÀ» ¾ß±âÇϸç, ¹ß¿­ µîÀÇ Àü½Å Áõ»óÀ» µ¿¹ÝÇÑ´Ù. À§Ä¡, ¿øÀαՠµî¿¡ µû¶ó ±¸ºÐÇÑ´Ù.
  
  ¿¹¸¦ µé¾î, ´ë¿±¼º Æó·Å(lobar pneumonia)¶õ Æó·Å ±¸±Õ¿¡ ÀÇÇÑ ±Þ¼º Æä·ÅÀ¸·Î ÇÑ °³ ¶Ç´Â ¿©·¯ °³ÀÇ Æó¿±À» µû¶ó »ý±â´Â ±¤¹üÀ§ÇÑ »ïÃ⼺ °æÈ­°¡ Æ¯Â¡ÀΠº´À» ÁöĪÇÑ´Ù. À̰ÍÀº Æó·ÅÀÇ ¹ß»ýºÎÀ§¿¡ µû¶ó ºÎ¸£´Â ¸»ÀÌ´Ù. ±×¸®°í ¹ÙÀÌ·¯½ºÆó·Å(viral pneumonia)¶õ ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ ¹ß»ýÇϴ ¸ðµç Æó·ÅÀ» ¸»Çϴµ¥, À̰ÍÀº ¿øÀαտ¡ µû¶ó ÁöĪÇÑ ¸»ÀÌ´Ù.
¿µ¹® aspiration pneumonia ÇÑ±Û ÈíÀÎÆó·Å
¼³¸í   
  À½½Ä¹°ÀÇ Â±â°°Àº À̹°ÀÌ ±âµµ¿¡ µé¾î°¡ ÀÌÂ÷ÀûÀ¸·Î »ý±â´Â Æó·Å. À½½Ä¹°À̳ª ÀÔ¾ÈÀÇ ¹Ì»ý¹°ÀÌ ½Äµµ·Î ³Ñ¾î°¡Áö ¾Ê°í ±âµµ·Î À߸ø ÈíÀεǾ߱âµÇ´Â Æó·ÅÀ» ¸»ÇÑ´Ù. ÈíÀΠ¹°ÁúÀǠƯ¼º¿¡ µû¶ó¼­ ¼¼ °¡Áö ÁõÈıºÀ» Æ÷ÇÔÇÑ´Ù. ¨ç È­ÇÐÀû Æó·ÅÀº Á÷Á¢ÀûÀ¸·Î Æó¿¡ À¯ÇØÇÑ ¹°ÁúÀ» ÈíÀÎÇßÀ» ¶§ ÀϾ¸ç, ±Þ¼º È£Èí°ï¶õ, ºü¸¥ È£Èí, ºü¸¥¸ÆÀÌ ³ªÅ¸³ª°í µ¿¹ÝµÇ´Â Áõ»óÀº ÁַΠû»öÁõ, ±â°üÁö °æ·Ã, ¿­ µîÀÌ´Ù. ¨è Çϱ⵵ÀÇ ¼¼±Õ¼º °¨¿°ÀÌ ÈíÀμº Æó·ÅÀÇ °¡Àå ÈçÇÑ ÇüÅ·Î, ±âħ, ¹ß¿­, °í¸§°¡·¡ Áõ»óÀ» ³ªÅ¸³½´Ù. ¨é Çϱ⵵ÀÇ ±â°èÀû Æó¼â´Â Æ¯º°ÇÑ ¹°Áú, Æ¯È÷ ¶¥Äá, ÀÛÀº °í±âµ¢¾î¸®¿¡ ÀÇÇØ ÈíÀεǾúÀ» ¶§ ÀϾ¸ç, ÈíÀΠ¹°Áú°ú ±âµµÀÇ Á÷°æ¿¡ µû¶ó Áõ»óÀº ´Ù¸£´Ù. ±â°ü¿¡¼­ ¸·È÷¸é Á¾Á¾ È£Èí°ï¶õ°ú ÇÔ²² »ç¸Á¿¡ À̸£±âµµ Çϸç, Çϱ⵵ ¾Æ·¡ ºÎºÐ¿¡¼­ ÈíÀÎÀÌ ÀϾ¸é ¸¸¼º ±âħÀÌ ¹ß»ýÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody-mediated hypersensitivity
    Ç×ü¸Å°³°ú¹Î¼º
  • atopic hypersensitivity
    ¾ÆÅäÇǰú¹Î¼º
  • contact hypersensitivity
    Á¢Ã˰ú¹Î(Áõ)
  • cutaneous basophil hypersensitivity
    ÇǺÎÈ£¿°±¸°ú¹Î(Áõ)
  • cytotoxic hypersensitivity
    ¼¼Æ÷µ¶¼º°ú¹Î¼º
  • cell-mediated hypersensitivity
    ¼¼Æ÷¸Å°³°ú¹Î¼º
  • delayed-type hypersensitivity
    Áö¿¬°ú¹Î(¼º)
  • denervation hypersensitivity
    Å»½Å°æ°ú¹Î¼º
  • dermal hypersensitivity
    ÇǺΰú¹Î¼º
  • hypersensitivity
    1. °ú¹Î(¼º) 2. °ú¹Î(Áõ)
  • hypersensitivity angitis
    °ú¹Î¸Æ°ü¿°
  • hypersensitivity disorder
    °ú¹ÎÁúȯ
  • hypersensitivity myocarditis
    °ú¹Î½É±Ù¿°
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
  • hypersensitivity vasculitis
    °ú¹ÎÇ÷°ü¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity
    °ú¹Î
  • pneumonia
    Æó·Å, ÇãÆÄ¿°
  • acute pneumonia
    ±Þ¼ºÆó·Å
  • aspiration pneumonia
    ÈíÀÎÆó·Å
  • atypical pneumonia
    ºñÁ¤ÇüÆó·Å
  • giant cell pneumonia
    °Å´ë¼¼Æ÷Æó·Å
  • interstitial pneumonia
    °£ÁúÆó·Å, »çÀÌÁúÆó·Å
  • nosocomial pneumonia
    º´¿ø³»Æó·Å
  • Streptococcus pneumonia
    Æó·Å»ç½½¾Ë±Õ, Æó·Å¿¬¼â±¸±Õ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody-mediated hypersensitivity
    Ç×ü¸Å°³°ú¹Î
  • atopic hypersensitivity
    ¾ÆÅäÇǰú¹Î
  • cell-mediated hypersensitivity
    ¼¼Æ÷¸Å°³°ú¹Î
  • contact hypersensitivity
    Á¢Ã˰ú¹Î
  • cutaneous basophil hypersensitivity
    ÇǺÎÈ£¿°±¸°ú¹Î
  • cytotoxic hypersensitivity
    ¼¼Æ÷µ¶¼º°ú¹Î
  • delayed-type hypersensitivity
    Áö¿¬°ú¹Î
  • denervation hypersensitivity
    ½Å°æÁ¦°Å°ú¹Î
  • denervation hypersensitivity test
    Å»½Å°æ°ú¹Î¹ÝÀÀ°Ë»ç
  • dermal hypersensitivity
    ÇǺΰú¹Î
  • hypersensitivity disorder
    °ú¹ÎÁúȯ
  • hypersensitivity
    °ú¹Î
  • hypersensitivity angitis
    °ú¹Î¸Æ°ü¿°
  • hypersensitivity myocarditis
    °ú¹Î½É±Ù¿°
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity pneumonia
    °ú¹Î¼º Æó·Å.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • angiitis,hypersensitivity
    °ú¹Î¼º(ΦÚÂàõ)
  • antibody-mediated hypersensitivity
    Ç×ü¸Å°³ °ú¹Î¹ÝÀÀ
  • gluten hypersensitivity
    ±Û·çÅÙ°ú¹Î¹ÝÀÀ
  • hypersensitivity
    °ú¹Î¼º
  • hypersensitivity
    °¨°¢°ú¹Î¼º
  • hypersensitivity =hypersensitiveness
    °ú¹Î¼º, °ú¹ÎÁõ.
  • hypersensitivity angitis
    °ú¹Î¼º ¸Æ°ü¿°.
  • hypersensitivity angitis
    °ú¹Î¼º Ç÷°ü¿°(ΦÚÂàõ úìηæú)
  • hypersensitivity disorders
    °ú¹Î¼º Áúȯ(ΦÚÂàõ òðü´)
  • hypersensitivity myocarditis
    °ú¹Î¼º ½É±Ù¿°.
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
  • hypersensitivity reactions
    °ú¹Î¼º ¹ÝÀÀ(ΦÚÂàõ Úãëë)
  • hypersensitivity reactions,delayed-type
    Áö¿¬Çü(òÀæÅû¡)
  • hypersensitivity reactions,type i(anaphylactic)
    IÇü
  • hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
    IIÇü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity pneumonia
    °ú¹Î¼º Æó·Å.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • angiitis,hypersensitivity
    °ú¹Î¼º(ΦÚÂàõ)
  • antibody-mediated hypersensitivity
    Ç×ü¸Å°³ °ú¹Î¹ÝÀÀ
  • bacterial hypersensitivity
    ¼¼±Õ°ú¹ÎÁõ
  • basophil hypersensitivity
    È£¿°±¸ °ú¹Î¼º
  • basophilic hypersensitivity
    È£¿°±â±¸ °ú¹Î¹ÝÀÀ
  • cell mediated hypersensitivity
    ¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
  • cellular hypersensitivity
    ¼¼Æ÷¼º °ú¹Î¹ÝÀÀ
  • cellular hypersensitivity
    ¼¼Æ÷¼º°ú¹Î¹ÝÀÀ
  • contact hypersensitivity
    Á¢Ã˼º °ú¹Î¹ÝÀÀ
  • cutaneous basophil hypersensitivity
    ÇǺΠȣ¿°±¸ °ú¹Î ¹ÝÀÀ
  • cutaneous basophilic hypersensitivity
    ÇǺÎÈ£¿°±¸ °ú¹ÎÁõ
  • cystotxic hypersensitivity
  • delayed hypersensitivity
    ¸é ¿ª Áö¿¬Çü°ú¹ÎÁõ.
  • delayed hypersensitivity
    Áö¿¬Çü°ú¹ÎÁõ.
  • delayed hypersensitivity
    Áö¿¬Çü°ú¹ÎÁõ.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • interstitial plasma cell pneumonia
    °£Áú¼ºÇüÁú¼¼Æ÷Æó¿°
  • Pneumocystis carinii pneumonia
    ÆóÆ÷ÀÚÃæÆó¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody mediated hypersensitivity
    Ç×ü ¸Å°³ °ú¹ÎÁõ(ù÷ô÷ØÚ˿ΦÚÂñø)
  • contact hypersensitivity
    Á¢Ã˰ú¹ÎÁõ(ïÈõºÎ¦ÚÂñø)
  • delayed-type hypersensitivity
    Áö¿¬Çü °ú¹ÎÁõ(òÀæÅû¡Î¦ÚÂñø)
  • hypersensitivity
    °ú¹Î¼º(ΦÚÂàõ)
  • immediate-type hypersensitivity
    Áï½ÃÇü °ú¹ÎÁõ(ñíãÁúþΦÚÂñø)
  • induced hypersensitivity
    À¯µµ°ú¹ÎÁõ(ë¯ÓôΦÚÂñø)
  • spontaneous hypersensitivity
    ÀÚ¿¬ °¨¼ö¼º(í»æÔÊïáôàõ)
  • tuberculin hypersensitivity
    Åõº£¸£Ä𸰠°ú¹Î¼º(ΦÚÂàõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity
    °ú¹Î¼º, °ú¹ÎÁõ
  • aspiration pneumonia
    ÈíÀμºÆó·Å
  • diffuse interstitial pneumonia
    ¹Ì¸¸¼º°£Áú¼ºÆó·Å
  • eosinophilic pneumonia
    È£»ê±¸¼ºÆó·Å
  • interstitial pneumonia
    °£Áú¼ºÆó·Å
  • lipoid pneumonia
    ¸®Æ÷À̵åÆó·Å, À¯ÁöÁúÆó·Å
  • lobar pneumonia
    ´ë¿±¼ºÆó·Å
  • migratory pneumonia
    À¯ÁÖÆó·Å
  • mycotic pneumonia
    Áø±Õ¼ºÆó·Å
  • oil pneumonia
    À¯¼ºÆó·Å
  • organizing pneumonia
    ±âÁúÈ­ÇÏ´Â Æó·Å
  • plasma cell pneumonia
    ÇüÁú¼¼Æ÷¼ºÆó·Å
  • pneumococcal pneumonia
    Æó·Å±¸±Õ(¼º)Æó·Å
  • pneumonia
    Æó·Å
  • rheumatic pneumonia
    ·ù¸¶Æ¼½º¼ºÆó·Å
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
HP Hypersensitivity Pneumonitis
  = Extrinsic Allergic Alveolitis
CBH chronic benign hepatitis; cutaneous basophilic hypersensitivity
CHS central hypoventilation syndrome; Chediak-Higashi syndrome; cholinesterase; chondroitin sulfate; com...
CSH carotid sinus hypersensitivity; chronic subdural hematoma; combat support [army] hospital; cortical ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CSH Carotid sinus hypersensitivity
CH Contact hypersensitivity
CHS Contact hypersensitivity
CBH Cutaneous basophil hypersensitivity
DTH Delayed Type Hypersensitivity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • cell-mediated hypersensitivity
    ¼¼Æ÷ ¸Å°³¼º °ú¹ÎÁõ
    TuberculinÇü Çdz» ¹ÝÀÀÀ» ´ëÇ¥·Î ÇÑ´Ù. ¼¼Æ÷¼º ¸é¿ª ¹ÝÀÀÀÇ ÇÑ ÇüÅÂ. Ç׿ø¿¡ ÀÇÇÏ¿© °¨ÀÛµÈ µ¿¹°ÀÇ Çdz»¿¡ ÀçÂ÷ Ç׿øÀ» ÁÖ»çÇÔÀ¸·Î½á ¼ö ½Ã°£À¸·ÎºÎÅÍ 36½Ã°£ ÈÄ¿¡ ¹ßÀû, °æ°áÀ» ¼ö¹Ý½ÃŰ´Â Á¾Ã¢ÀÌ ÁÖ»ç ºÎÀ§¿¡ ¹ß»ýÇÏ´Â ¹ÝÀÀÀÌ´Ù.
  • cellular hypersensitivity
    ¼¼Æ÷¼º °ú¹Î¹ÝÀÀ
    ¼¼Æ÷¿¡ ´ëÇÏ¿© °úÀ×¹ÝÀÀÀ» ³ªÅ¸³»´Â ¹æÇâÀ¸·Î ¹ÝÀÀ¼ºÀÌ º¯È­ÇÑ »óÅÂ.
  • cutaneous hypersensitivity
    ÇǺΠ°ú¹ÎÁõ
  • delayed hypersensitivity
    Áö¿¬Çü °ú¹Î¼º
  • denervation hypersensitivity test
    Å»½Å°æ °ú¹Î ¹ÝÀÀ °Ë»ç
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • hypersensitivity angitis
    °ú¹Î¼º ¸Æ°ü¿°
  • immediate hypersensitivity
    Áï½Ã °ú¹ÎÁõ, Áï½ÃÇü °ú¹ÎÁõ, Áï°¢ °ú¹Î ¹ÝÀÀ
    ¹Ì¸® ƯÁ¤ÀÇ Ç׿ø¿¡ ÀÇÇÏ¿© °¨À۵ǰí ÀÖ´Â »ýü°¡ µ¿ÀÏ Ç׿øÀÇ 2ȸ ° ÀÌÈÄÀÇ Åõ¿©¿¡ ÀÇÇÏ¿© Á¤»óº¸´Ù °ú¹ÎÇÑ ¹ÝÀÀÀ» ÀÏÀ¸Å²´Ù. À̶§ÀÇ ¹ÝÀÀÀ¸·Î ÀÌ Ç׿ø°ú »ýü ³»¿¡ »ý»êµÈ Ç×ü¿¡ ÀÇÇÏ¿© ƯÀÌÀûÀÎ °áÇÔÀÌ ÀϾ »ýüÁ¶Á÷¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å²´Ù.
  • streptococcal hypersensitivity
    ¿¬¼â ±¸±Õ °ú¹Î¼º
  • acute pneumonia
    ±Þ¼º Æó·Å
    ¹ÙÀÌ·¯½º, ¼¼±Õ µî¿¡ ÀÇÇØ¼­ »ý±â´Â Æó ½ÇÁúÀÇ ±Þ¼º ¿°ÁõÀÌ°í º´º¯ÀÇ Áß½ÉÀº ÆóÆ÷ »óÇÇ, ¼¼Æ÷ °­¿¡ ÀÖÀ¸¸ç, ÆóÆ÷³»¿¡ ´Ù·®ÀÇ Ä§Ãâ¹°ÀÌ Ãæ¸¸ÇØ X-¼± Çʸ§ »ó¿¡¼­´Â ±â°üÁö °­À» Á¦¿ÜÇÏ°í ±ÕµîÇÑ ±×¸²ÀÚ·Î µÚµ¤ÀδÙ. Àü¿¡´Â °¨¿° Áúȯ Áß »óÀ§¸¦ Â÷ÁöÇϰí ÀÖ¾ú´Âµ¥ Ç×»ý ¹°ÁúÀÇ µîÀåÀ¸·Î °Ý°¨Çß´Ù. ÃÖ±Ù¿¡´Â ¿ø³»°¨¿°¿¡ µû¸¥ ³­Ä¡ÀÇ ±×¶÷ À½¼º±Õ °¨¿°ÀÌ Áõ°¡ Ãß¼¼¿¡ ÀÖ´Ù.
  • acute tuberculous pneumonia
    ±Þ¼º °áÇÙ¼º Æó·Å
    °áÇÙÀÌ °¨¿°µÇ¾î º¸Åë ¸¸¼º À°¾ÆÁ¾¼º ¿°ÁõÀ» ¾ß±âÇÏ´Â ÀϹÝÀûÀÎ °æ¿ì¿Í ´Þ¸® ±Þ¼º Æó·Å°ú °°ÀÌ ±Þ¼º »ïÃ⼺ ¿°ÁõÀ¸·Î ³ªÅ¸³ª´Â °æ¿ì·Î¼­ ÀúÇ×·ÂÀÌ ¾àÇÑ »ç¶÷¿¡°Ô º¼ ¼ö ÀÖ´Ù.
  • aspiration pneumonia
    ÈíÀμº Æó·Å, ¼ºÇÏ Æó·Å, ¼º¿¬ÇÏ Æó·Å, ¿¬Çϼº Æó·Å, ¼º¿¬Çϼº Æó·Å, ÈíÀÔ¼º Æó¿°
  • bacterial pneumonia
    ¼¼±Õ¼º Æó·Å
    ¼¼±Õ¿¡ ÀÇÇÑ °æÈ­¸¦ µ¿¹ÝÇÏ´Â ÆóÀÇ ¿°Áõ.
  • caseous pneumonia
    °Ç¶ô¼º Æó·Å
    ÆóÀÇ °Ç¶ô¼º º¯È­¸¦ ¼ö¹ÝÇÏ´Â °áÇÙ¼º Æó·Å. »ïÃ⼺ º¯È­°¡ ½ÉÇÑ »óÅ¿¡¼­ ÀϺΰ¡ °Ç¶ô º¯¼ºÀ» ÇÑ ¿°Áõ º´¼Ò·Î µÇ¾î ÀÖ´Ù. Áõ½Ä¼º °áÇÙ°ú ´Þ¶ó Àå¾×, ¼¶À¯¼Ò, ¹éÇ÷±¸, ´ë´ÜÇÙ±¸ µîÀÇ »ïÃâÀÌ ½ÉÇϰí, Æó¿± Àüü°¡ ±¤¹üÀ§ÇÏ°Ô Ä§½ÄµÉ À§ÇèÀÌ ¸¹´Ù. °áÇÙ±Õ¿¡ ´ëÇÑ ¾Ë·¹¸£±â°¡ °ü°èµÈ °ÍÀ¸·Î »ý°¢µÇ°í ÀÖ´Ù.
  • eosinophilic pneumonia
    È£»ê±¸¼º Æó·Å
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
vasculitis, hypersensitivity Heterogeneous group of disorders characterised by a vasculitic syndrome presumed to be associated with a hypersensitivity reaction following exposure to an antigen such as an infectious agent, a drug, or other foreign or endogenous substance.
(12 Dec 1998)
respiratory hypersensitivity A form of hypersensitivity affecting the respiratory tract. It includes asthma and hay fever.
(12 Dec 1998)
milk hypersensitivity Allergic reaction to milk (usually cow's milk) or milk products. In infants the hypersensitivity is manifested by colic, vomiting, diarrhoea, rhinitis, wheezing, etc. Milk hypersensitivity should be differentiated from lactose intolerance, an intolerance to milk as a result of congenital deficiency of lactase.
(12 Dec 1998)
contact hypersensitivity <pathology> A type of immune-mediated inflammatory skin rash that results from an allergy to a particular substance (for example jewelry dermatitis, poison ivy, neomycin ointment, etc.).
(27 Sep 1997)
hypersensitivity <immunology> A state of altered reactivity in which the body reacts with an exaggerated immune response to a foreign substance. Hypersensitivity reactions are classified as immediate or delayed, types I and IV, respectively, in the Gell and Coombs classification of immune responses.
(18 Nov 1997)
hypersensitivity, delayed An increased reactivity to specific antigens mediated not by antibodies but by cells.
(12 Dec 1998)
hypersensitivity, immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability.
(12 Dec 1998)
hypersensitivity pneumonitis <radiology> Aka: chronic extrinsic allergic alveolitis, pathology: proliferation of epithelial cells, elaboration of reticulum fibres, findings: interstitial reticulonodular pattern (basilar distribution), volume loss (cicatrization atelectasis) in upper lobes, pleural effusion (rare), lymph node enlargement may occur
(12 Dec 1998)
hypersensitivity reaction <immunology> The bodys response to an allergic stimulus. This can be localised to one area or generalised and may include: rash, itching, hives, swelling, difficulty breathing, and/or low blood pressure.
(27 Sep 1997)
hypersensitivity vasculitis An acute form of vasculitis which may affect the skin only, but also may involve other organs, with a polymorphonuclear infiltrate in the walls of and surrounding small (dermal) vessels. Nuclear fragments are formed by karyorrhexis of the neutrophils.
See: leukocytoclastic vasculitis.
Synonym: allergic angiitis, hypersensitivity vasculitis.
(05 Mar 2000)
delayed hypersensitivity <immunology> Hypersensitivity (increased reaction by the body to a foreign substance such as an antigen or allergen) that does not appear until 24 to 48 hours after the body is exposed to the foreign substance.
(09 Oct 1997)
delayed type hypersensitivity <immunology> Hypersensitivity (increased reaction by the body to a foreign substance such as an antigen or allergen) that does not appear until 24 to 48 hours after the body is exposed to the foreign substance.
(09 Oct 1997)
DNAse i hypersensitivity site <molecular biology> A site on a DNA molecule that is especially prone to being cut apart by the endonuclease enzyme DNase I, which breaks down DNA into smaller fragments by cleaving phosphodiester bonds. These sites tend to be near active genes, which are regularly transcribed.
(09 Oct 1997)
drug hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
(12 Dec 1998)
immediate hypersensitivity An exaggerated immune response mediated by antibodies, in particular IgE.
See: allergy.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity
    °ú¹ÎÁõ
  • pneumonia
    Æó·Å
  • double pneumonia
    (ÀÇ)¾çÃø Æó·Å
  • pneumonia
    Æó·Å
  • primary atypical pneumonia
    1Â÷¼º ºñÁ¤Çü Æó·Å
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á